Miramistin rr d / places. approx. 0.01% 50ml bottle with urological applicator (complete with gynecological attachment)

Dosage form

Solution for topical application 0.01% colorless, transparent, foaming on shaking.

Release form

50 ml polyethylene bottle with gynecological attachment

Structure

1 l

benzyldimethyl-myristoylamino-propylammonium chloride monohydrate (miramistin) 100 mg

Excipients: purified water - up to 1 liter.

pharmachologic effect

MiramistinВ® has a broad spectrum of antimicrobial activity, including hospital strains resistant to antibiotics.

The drug has a pronounced bactericidal effect against gram-positive (Staphylococcus spp., Streptococcus spp., Streptococcus pneumoniae, etc.), gram-negative (Pseudomonas aeruginosa, Escherichia coli, Klebsiella spp., Etc.), aerobic and anaerobic bacteria, determined microbial associations, including hospital strains with multidrug resistance to antibiotics.

It has an antifungal effect on ascomycetes of the genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata, etc.) and yeast-like fungi (Candida albicans, Candida tropicalis, Candida krusei, Pityrosporum orbiculare, Malassezia, etc.) (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violacent, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis, etc.), as well as other microorganisms in the form of pathogenic including fungal microflora with resistance to chemotherapy drugs.

It has an antiviral effect, is active against complex viruses (herpes viruses, human immunodeficiency virus and others).

MiramistinВ® acts on sexually transmitted diseases (Chlamydia spp., Treponema spp., Trichomonas vaginalis, Neisseria gonorrhoeae and others).

Effectively prevents infection of wounds and burns.

It activates the regeneration processes.

Stimulates protective reactions at the site of application, by activating the absorption and digestion functions of phagocytes, potentiates the activity of the monocytic-macrophage system.

It has a pronounced hyperosmolar activity, as a result of which it relieves wound and perifocal inflammation, absorbs purulent exudate, contributing to the formation of a dry scab.

Does not damage granulation and viable skin cells, does not inhibit marginal epithelization.

Does not possess local irritating effect and allergenic properties.

Pharmacokinetics

When applied topically, the drug does not have the ability to be absorbed through the skin and mucous membranes.

Side effects

Local reactions: in some cases - a slight burning sensation, which disappears on its own in 15-20 seconds and does not require discontinuation of the drug.

Possibly: allergic reactions.

Selling features

Available without a prescription

Indications

For use in surgery, traumatology:

- prevention of suppuration and treatment of purulent wounds

- treatment of purulent-inflammatory processes of the musculoskeletal system.

For use in obstetrics, gynecology:

- prevention and treatment of suppuration of postpartum injuries, perineal and vaginal wounds, postpartum infections

- prevention and treatment of inflammatory diseases (vulvovaginitis, endometritis).

For use in combustiology:

- treatment of superficial and deep burns of II and III A degree

- preparation of burn wounds for dermatoplasty.

For use in dermatology, venereology:

- treatment and prevention of pyoderma and dermatomycosis, candidiasis of the skin and mucous membranes, mycoses of the feet

- individual prevention of sexually transmitted diseases (including syphilis, gonorrhea, chlamydia, trichomoniasis, genital herpes, genital candidiasis).

For use in urology:

- complex treatment of acute and chronic urethritis and specific urethroprostatitis (chlamydia, tricho

Name ENG

MIRAMISTIN

Clinical and pharmacological group

Topical antiseptic

ATX code

Quaternary ammonium compounds

Dosage

0.01% x 50ml

Structure

1 l.

benzyldimethyl-myristoylamino-propylammonium chloride monohydrate (miramistin) 100 mg.

Excipients: purified water - up to 1 liter.

Indications

Prevention of suppuration and treatment of purulent wounds in surgical and obstetric practice

- superficial and deep burns

- inflammatory diseases of the female genital area

- individual prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, genital herpes, genital candidiasis)

- acute and chronic urethritis and urethroprostatitis of a specific and non-specific nature

- periodontitis, stomatitis, hygienic treatment of removable dentures

- acute and chronic otitis media, sinusitis, tonsillitis, laryngitis (as part of complex therapy).

Contraindications

Hypersensitivity to the drug.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

INN / Active ingredient

benzyldimethyl-myristoylamino-propylammonium chloride monohydrate

Specifications

Category

Antiseptics and disinfectants

Scope of the drug

General

Release form

Solution

Manufacturer country

Russia

Package quantity, pcs

one

Minimum age from

3 years old

Way of introduction

Vaginally

,

Locally

,

Outwardly

,

On the skin

Vacation conditions

Without recipe

Brand name

Infamed

Components

urological applicator, gynecological nozzle

The amount of the dosage form in the primary package

50 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antiseptic

Anatomical and therapeutic characteristics

D08AJ Quaternary ammonium compounds

Dosage form

Topical solution

Expiration date in days

1095

The target audience

Children

Package weight, g

fifty

Mode of application

:

Adults < br> When used in surgery, traumatology, combustiology for prophylactic and therapeutic purposes, they irrigate the surface of wounds and burns, loosely tamp wounds and fistulous passages, fix gauze swabs moistened with the drug. The treatment procedure is repeated 2-3 times / day for 3-5 days. A highly effective method of active drainage of wounds and cavities with a daily consumption of up to 1 liter of the drug. < br> When used in obstetrics, gynecology for the prevention of postpartum infection, it is used in the form of vaginal irrigation before delivery (5-7 days), in childbirth after each vaginal examination and in the postpartum period, 50 ml of the drug in the form of a tampon with an exposure of 2 hours, within 5 days. When women are delivered by cesarean section, the vagina is treated immediately before the operation, during the operation - the uterine cavity and an incision on it,and in the postoperative period, tampons moistened with the drug are inserted into the vagina with an exposure of 2 hours for 7 days. Treatment of inflammatory diseases is carried out in a course of 2 weeks by intravaginal administration of tampons with the drug, as well as by the method of drug electrophoresis. < br> For the prevention of sexually transmitted diseases, the drug is effective if it is applied no later than 2 hours after intercourse. Introduce the contents of the bottle with the urological applicator into the urethra for 2-3 minutes: men (2-3 ml), women (1-2 ml) and into the vagina (5-10 ml). Treat the skin of the inner surfaces of the thighs, pubis, genitals. After the procedure, it is recommended not to urinate for 2 hours. < br> In the complex treatment of urethritis and urethroprostatitis, 2-3 ml of the drug is injected into the urethra 1-2 times / day,the course of treatment is 10 days. < br> With purulent sinusitis - during puncture, the maxillary sinus is washed with a sufficient amount of the drug. Tonsillitis, pharyngitis and laryngitis are treated by rinsing the throat and / or irrigating with a spray nozzle by pressing 3-4 times 3-4 times / day. The amount of the drug for 1 rinse is 10-15 ml. < br> With stomatitis, gingivitis, periodontitis, it is recommended to rinse the mouth with 10-15 ml of the drug 3-4 times / day. < br> < br> Children < br> In case of acute pharyngitis and / or exacerbation of chronic tonsillitis, the pharynx is irrigated with a spray nozzle. Children aged 3-6: by pressing once on the head of the spray nozzle (3-5 ml per irrigation), 3-4 times / day children aged 7-14 years by double pressing (5-7 ml per irrigation), 3-4 times / day children over 14 years old by pressing 3-4 times (10-15 ml per irrigation), 3-4 times / day. The duration of therapy is from 4 to 10 days, depending on the timing of the onset of remission. < br> < br> Terms of use of the drug < br> The drug is ready for use. < br> Instructions for using the packaging with a spray attachment < br> 1. Remove the cap from the bottle. < br> 2. Remove the supplied spray nozzle from the protective packaging. < br> 3. Attach the spray nozzle to the bottle. < br> 4. Activate the spray nozzle by pressing again.Instructions for the use of packaging with a spray attachment < br> 1. Remove the cap from the bottle. < br> 2. Remove the supplied spray nozzle from the protective packaging. < br> 3. Attach the spray nozzle to the bottle. < br> 4. Activate the spray nozzle by pressing again.Instructions for the use of packaging with a spray attachment < br> 1. Remove the cap from the bottle. < br> 2. Remove the supplied spray nozzle from the protective packaging. < br> 3. Attach the spray nozzle to the bottle. < br> 4. Activate the spray nozzle by pressing again.

Information on technical characteristics, delivery set, country of manufacture